Claim Missing Document
Check
Articles

Found 3 Documents
Search

Perbandingan faktor resiko aorta abdominal dilatasi pada penderita penyakit jantung koroner dengan menggunakan ekokardiografi Yuke Sarastri; Andre Pasha Ketaren; Nizam Akbar; Sutomo Kasiman; Zulfikri Mukhtar; Tengku Winda Ardini; Rosmaliana dr; Abdullah Afif Siregar
Majalah Kedokteran Nusantara The Journal Of Medical School Vol 45, No 3 (2012): The Journal of Medical School
Publisher : Fakultas Kedokteran USU

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background : Patients with coronary artery disease share common risk factors as abdominal aortic aneurysm (AAA), in which screening for AA dilatation is recommended. Transthoracic echocardiography (TTE) may offer the opportunity to evaluate the cardiac function and to screen for AA dilatation during the same examination.Aims : This study aimed to compare risk factors for abdominal aortic dilatation with abdominal aorta index in patients with coronary artery disease, and to evaluate the feasibility of AA dilatation screening at bedside using TTE in population with CAD. Methods : This is a cross-sectional study of patients with CAD. The abdominal aortic was measured at the end of a regular TTE performed in consecutive patients admitted in coronary care unit of Haji Adam Malik Hospital Medan using an echocardiography machine.Results : We enrolled 75 patients with mean age 56 (SD 10) years. Dilatation of abdominal aortic was observed in 21 patients (28%). From the analysis obtained a significant relationship between history of acute myocardial infarction with dilatation abdominal aorta (P = 0.04).Conclusion : Overall, the prevalence of dilatation of abdominal aortic increased with age and history of AMI. In regard to the simplicity, screening for AA dilatation during TTE may be of value for patients with CAD, especially in elder patients. Keywords : echocardiography; dilatation of abdominal aortic; coronary artery disease
Description of Clinical Severity, Laboratory Results, and ECG of COVID-19 Patients Who Received Doses I and II of the COVID-19 Vaccine at Haji Adam Malik General Hospital from April to August 2021 Shafira Pramesi Putri; Andika Sitepu; Yuke Sarastri; Setia Putra Tarigan
Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI) Vol. 4 No. 4 (2022): Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI)
Publisher : TALENTA Publisher, Universitas Sumatera Utara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32734/jetromi.v4i4.11000

Abstract

Introduction: COVID-19 patients with comorbidities (hypertension or cardiovascular disease) have a high mortality rate and are at high risk of showing severe symptoms of COVID-19. One of the preventions to avoid COVID-19 is to vaccinate against COVID-19. The COVID-19 vaccine has proven safe and effective in patients with comorbidities because the vaccine can prevent severe symptoms of COVID-19. Aim: To describe the clinical severity, laboratory results, and ECG of COVID-19 patients with cardiovascular comorbidities who received the first and second doses of COVID-19 vaccination at Haji Adam Malik General Hospital from April to August 2021. Methods: A descriptive retrospective study using a cross-sectional study design. Total sampling was used, which fits the inclusion and exclusion criteria. Results: Out of the 71 COVID-19 patients with cardiovascular comorbidities, the majority were found to be male patients (57.7%), aged ≥ 65 years (22.5%), with comorbid hypertension (84.5%), and had received vaccine dose II (97.2%). Most patients had mild symptoms (47.9%), abnormal ECG results (73.2%), and varied laboratory results. Conclusion: Most patients had received the second COVID-19 vaccine, showing moderate symptoms of COVID-19, abnormal ECG results, and varied laboratory results.
Obstructive Sleep Apnea in Patients with Heart Failure and Atrial Fibrillation Lubis, Anggia Chairuddin; Yuke Sarastri; Cut Aryfa Andra; Nadiah Masyab; Hana Fauziyah
Sumatera Medical Journal Vol. 8 No. 3 (2025): Sumatera Medical Journal (SUMEJ)
Publisher : Talenta Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32734/sumej.v8i3.16701

Abstract

Background: Obstructive sleep apnea (OSA) is an independent risk factor for heart failure and atrial fibrillation. Therefore, effective detection and management of OSA are essential. Objective: The study aimed to determine how common obstructive sleep apnea is among patients with heart failure and atrial fibrillation. Methods: We performed a cross-sectional study assessing the prevalence of OSA in hospitalized patients with both conditions, following the latest European Society of Cardiology Guidelines for heart failure assessment and using polysomnography to evaluate OSA. Results: The study included 30 subjects; 22 (73.3%) were men, and 18 (60%) were over 60 years old. Polysomnography revealed that 23 (80.0%) had OSA, with 4 (23.5%) in the severe category and an average AHI of 18.3 ± 14.7. Among participants, 11 (65%) with ejection fraction ≤ 40%, 12 (40%) had obesity, 11 (36.7%) had Type 2 diabetes, 19 (63.6%) had hypertension, 20 (66.7%) had coronary artery disease, and 3 (10%) had a history of stroke. Most participants (60%) had a history of smoking. Conclusion: This study shows a high prevalence of OSA among patients with heart failure and atrial fibrillation, especially in men and those with reduced ejection fraction.